Məzmuna keç
  • Azeri Light98.79 $▲0.03%
  • Brent neft89.37 $▼0.02%
  • WTI neft82.23 $▼0.15%
  • Avropa qazı (TTF)81.11 €▼5.12%
  • Təbii qaz (ABŞ)3.374 $▲0.03%
  • Qızıl3 735 $▼0.12%
  • Gümüş45.29 $▲0.45%
  • Pambıq80.23 ¢▼1.40%
  • Buğda587.25 ¢▲0.60%
  • Bitcoin63 493 $▲0.81%
  • Ethereum1 804 $▲1.63%
  • S&P 5007 324▼0.23%
14°Bakı
  • USD1.7000
  • EUR1.8637▼0.0044
  • 100 RUB2.0630▼0.0057
  • GBP2.2325▼0.0111
  • TRY0.0337
  • AED0.4628
  • CNY0.2550
  • GEL0.6564▲0.0011
  • 100 KZT0.3826▼0.0004
  • UAH0.0377▲0.0001
  • 100 JPY1.0653▼0.0028
  • CHF2.0151▼0.0079
  • USD1.7000
  • EUR1.8637▼0.0044
  • 100 RUB2.0630▼0.0057
  • GBP2.2325▼0.0111
  • TRY0.0337
  • AED0.4628
  • CNY0.2550
  • GEL0.6564▲0.0011
  • 100 KZT0.3826▼0.0004
  • UAH0.0377▲0.0001
  • 100 JPY1.0653▼0.0028
  • CHF2.0151▼0.0079
Dünya

Çin koronavirusa təsir edən dərmanın adını açıqladı

epa04368952 A Fujifilm Holdings employee displays Avigan tablets, an experimental drug developed and manufactured by Japanese drug maker Toyama Chemical Co., Ltd. ,in Tokyo, Japan, 26 August 2014. The generic name of the Avigan drug is Favipiravir. Japanese Chief Cabinet Secretary Yoshihide Suga said on 25 August 2014 during a regular news conference that Japan was ready to provide an experimental drug developed by Japan's drug manufacturer Toyama Chemical Co., Ltd., subsidiaries under Fujifilm Holdings, to fight against the global tide of the deadly Ebola virus, if the World Health Organization (WHO) requests it. The drug, called Avigan, is a tablet-format anti-influenza drug developed by Toyama Chemical Co Ltd. It was approved in March by the Health Ministry. Avigan inhibits the replication of the virus genetic material inside infected cells, which prevents propagation. This is a new mechanism, compared with previous antiviral drugs that just tackle propagation, according to the company's website. In early August, the WHO declared the Ebola outbreak an international public health emergency. There is no available cure or vaccine for the deadly virus. The unapproved Ebola drug ZMapp was given to two US aid workers, who are said to have shown strong improvement, and a Spanish missionary priest, who died in Madrid this month. EPA/KIMIMASA MAYAMA
Xəbərlərimizi Google-da izləyinYeniliklərdən dərhal xəbərdar olunAbunə ol

Çin Milli Biotexnologiya İnkişaf Mərkəzinin prezidenti Zanq Xinmin koronavirusa təsir edəcək dərmanın adını açıqlayıb.

“HaberGlobal” məlumat verir ki, Z.Xinmin “Favipiravir” adlı dərmanın yeni növ koronavirusun sağalma müddətini 11 gündən 4 günə endirə bildiyini deyib.

O, bu qənaətə 80 xəstə üzərində tədqiqat apardıqdan sonra gəlib.

Z.Xinmin dərmanın yan təsirlərinin olmadığını da vurğulayıb.

“Favipiravir”in 2014-cü ildən Yaponiyada apteklərdə satıldığı qeyd edilib.

MüəllifBusaat Media Group

Xəbəri paylaş

busaat.az/?p=5957